VIMERGY, LLC – Trademark Portfolio
Entity Type: 16
VIMERGY, LLC holds 16 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 13 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 3 Nice Classification classes. Currently, 10 trademarks are registered and 1 is pending. Notable registered marks include V, MICRO-C, VIMERGY, CELERYFORCE, and PROPOLISPURE. The owner is based in Coral Springs, FL.
3301 North University Drive, Suite #300
Coral Springs, FL 33065
Showing of trademarks Trademarks
Trademark Classifications
VIMERGY, LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Advertising; business management; business administration; office functions
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does VIMERGY, LLC have?
VIMERGY, LLC has 16 U.S. trademarks filed with the USPTO. Of these, 10 registered, 1 pending, 5 abandoned.
What trademark classes does VIMERGY, LLC file in?
VIMERGY, LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 35 (Advertising & Business), Class 41 (Education & Entertainment). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are VIMERGY, LLC's most well-known trademarks?
VIMERGY, LLC's registered trademark portfolio includes well-known marks such as V, MICRO-C, VIMERGY, CELERYFORCE, and PROPOLISPURE. These are among 10 currently registered trademarks in the portfolio.
What is VIMERGY, LLC's trademark registration success rate?
VIMERGY, LLC has a 67% trademark registration rate, with 10 out of 15 resolved applications resulting in successful registration. Currently, 1 application is pending review.